Trial Outcomes & Findings for Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement (NCT NCT04602741)
NCT ID: NCT04602741
Last Updated: 2026-05-22
Results Overview
Number of participants retained in the study through to post-intervention evaluation. The target is retaining 85% of participants recruited.
COMPLETED
NA
91 participants
6 months per participant in a 27 month period.
2026-05-22
Participant Flow
Participant milestones
| Measure |
A4i Intervention
App4Independence (A4i)
Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data.
Specific A4i functionality includes:
* Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources.
* Fostering illness self-management through evidence-informed content.
* A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated).
* Daily wellness and goal attainment check-ins.
* An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds.
* Passively collected data on phone use as a proxy for sleep.
* A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU).
A4i Intervention: 6 months of the provision of A4i on the individual's own device.
|
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
Overall Study
STARTED
|
43
|
48
|
|
Overall Study
COMPLETED
|
26
|
41
|
|
Overall Study
NOT COMPLETED
|
17
|
7
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Examining a Digital Health Approach for Advancing Schizophrenia Illness Self-management and Provider Engagement
Baseline characteristics by cohort
| Measure |
A4i Intervention
n=43 Participants
App4Independence (A4i)
Experimental: A4i Intervention App4Independence (A4i) The study intervention is the digital health platform A4i. A4i operates on the individual's own phone with or without data.
Specific A4i functionality includes:
* Addressing social isolation and cognitive challenges through personalized prompts, scheduling of activities, and connections to a range of resources.
* Fostering illness self-management through evidence-informed content.
* A peer-peer engagement platform that facilitates strategy/tip sharing between users (anonymous and moderated).
* Daily wellness and goal attainment check-ins.
* An ambient sound detector with an oscilloscope-type indicator that assists individuals with auditory hallucinations separate hallucinations from real sounds.
* Passively collected data on phone use as a proxy for sleep.
* A provider dashboard. Both control and experimental condition participants will be receiving standard outpatient care (TAU).
A4i Intervention: 6 months of the provision of A4i on the individual's own device.
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
Total
n=91 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32.5 years
STANDARD_DEVIATION 12.6 • n=2 Participants
|
29.2 years
STANDARD_DEVIATION 9.0 • n=4 Participants
|
30.8 years
STANDARD_DEVIATION 10.9 • n=6 Participants
|
|
Sex/Gender, Customized
man
|
27 Participants
n=2 Participants
|
27 Participants
n=4 Participants
|
54 Participants
n=6 Participants
|
|
Sex/Gender, Customized
woman
|
14 Participants
n=2 Participants
|
18 Participants
n=4 Participants
|
32 Participants
n=6 Participants
|
|
Sex/Gender, Customized
non-binary
|
2 Participants
n=2 Participants
|
3 Participants
n=4 Participants
|
5 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
White European Origin
|
16 Participants
n=2 Participants
|
20 Participants
n=4 Participants
|
36 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Afro-Caribbean or African Origin
|
11 Participants
n=2 Participants
|
7 Participants
n=4 Participants
|
18 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Indigenous
|
3 Participants
n=2 Participants
|
1 Participants
n=4 Participants
|
4 Participants
n=6 Participants
|
|
Race/Ethnicity, Customized
Other
|
13 Participants
n=2 Participants
|
20 Participants
n=4 Participants
|
33 Participants
n=6 Participants
|
|
Region of Enrollment
Canada · Born in Canada
|
31 Participants
n=2 Participants
|
33 Participants
n=4 Participants
|
64 Participants
n=6 Participants
|
|
Region of Enrollment
Canada · Born Elsewhere
|
12 Participants
n=2 Participants
|
15 Participants
n=4 Participants
|
27 Participants
n=6 Participants
|
|
Employment
Unemployed
|
17 Participants
n=2 Participants
|
17 Participants
n=4 Participants
|
34 Participants
n=6 Participants
|
|
Employment
Employed (incl. Self-Employed)
|
12 Participants
n=2 Participants
|
15 Participants
n=4 Participants
|
27 Participants
n=6 Participants
|
|
Employment
Volunteer Work/Unpaid
|
2 Participants
n=2 Participants
|
1 Participants
n=4 Participants
|
3 Participants
n=6 Participants
|
|
Employment
Student
|
11 Participants
n=2 Participants
|
13 Participants
n=4 Participants
|
24 Participants
n=6 Participants
|
|
Employment
Other
|
1 Participants
n=2 Participants
|
2 Participants
n=4 Participants
|
3 Participants
n=6 Participants
|
|
Relation Status
Single/Separated/Divorced/Widowed
|
38 Participants
n=2 Participants
|
35 Participants
n=4 Participants
|
73 Participants
n=6 Participants
|
|
Relation Status
Married/In a Relationship/Cohabitating with a Partner
|
5 Participants
n=2 Participants
|
13 Participants
n=4 Participants
|
18 Participants
n=6 Participants
|
|
Education
High School or Below
|
15 Participants
n=2 Participants
|
13 Participants
n=4 Participants
|
28 Participants
n=6 Participants
|
|
Education
University
|
23 Participants
n=2 Participants
|
34 Participants
n=4 Participants
|
57 Participants
n=6 Participants
|
|
Education
Graduate School
|
5 Participants
n=2 Participants
|
1 Participants
n=4 Participants
|
6 Participants
n=6 Participants
|
|
Diagnosis
Schizophrenia
|
21 Participants
n=2 Participants
|
25 Participants
n=4 Participants
|
46 Participants
n=6 Participants
|
|
Diagnosis
Schizophreniform
|
3 Participants
n=2 Participants
|
3 Participants
n=4 Participants
|
6 Participants
n=6 Participants
|
|
Diagnosis
Schizoaffective Disorder
|
9 Participants
n=2 Participants
|
13 Participants
n=4 Participants
|
22 Participants
n=6 Participants
|
|
Diagnosis
Other Specified Psychotic Disorder
|
10 Participants
n=2 Participants
|
7 Participants
n=4 Participants
|
17 Participants
n=6 Participants
|
PRIMARY outcome
Timeframe: Through recruitment process an average of 1 week during a 21 month recruitment period.Number of individuals successfully recruited into the trial with a target of 91.
Outcome measures
| Measure |
Participants
n=96 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
Recruitment
|
91 Participants
|
—
|
PRIMARY outcome
Timeframe: 6 months per participant in a 27 month period.Number of participants retained in the study through to post-intervention evaluation. The target is retaining 85% of participants recruited.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
Retention
|
26 Participants
|
41 Participants
|
PRIMARY outcome
Timeframe: Up to 6 months.Population: 0 individuals from the TAU group were analyzed since they did not have access to the mobile A4i intervention
Number of interactions with the app will be collected including information on the combined time and frequency of use for each participant.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
App Interactions
|
14.9 interactions
Standard Deviation 21.8
|
—
|
PRIMARY outcome
Timeframe: Up to 6 months.Safety/tolerability will be assessed through information gathered via all study-related interactions with significant safety concerns operationalized as one or more critical incidents occurring in which there is evidence of an association between the incident and App use.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
Incidence of Treatment-Emergent Adverse Events
|
0 Participants
|
0 Participants
|
PRIMARY outcome
Timeframe: Up to 6 months.Population: 0 individuals from the TAU group were analyzed since they did not have access to the mobile A4i intervention
Total number of posts liked for each participant will be collected.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
App Likes
|
24.6 app likes
Standard Deviation 70.5
|
—
|
SECONDARY outcome
Timeframe: Baseline-6 months.General symptomatology will be assessed using the 53-item, 5-point likert scale Brief Symptom Inventory. Range 0-212. Lower values are better.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
BSI: Psychiatric Symptoms
Pre-Intervention
|
53.0 score on a scale
Standard Deviation 38.7
|
61.5 score on a scale
Standard Deviation 40.5
|
|
BSI: Psychiatric Symptoms
Post-Intervention
|
39.4 score on a scale
Standard Deviation 34.3
|
53.3 score on a scale
Standard Deviation 42.8
|
|
BSI: Psychiatric Symptoms
Pre-Post Change
|
-13.7 score on a scale
Standard Deviation 23.4
|
-7.4 score on a scale
Standard Deviation 35.1
|
SECONDARY outcome
Timeframe: Baseline-6 months.Medication adherence will be measured using the 4-item Brief Adherence Rating Scale with responses obtained by both providers and participants to assess medication adherence. There are two indicators, both are pre-post changes, "days not taken" and "days taken less", and both are not scored as a percentage. The change scores for taking medication less (days taken less) and medication not taken (days not taken) were calculated as the difference from their 6 month score minus their baseline score. An value of "better" was assigned when the change score is \> 0, value of "no change" was assigned when the change score is = 0, and a value of "worse" value was assigned when the change score is \< 0.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
BARS: Medication Adherence
Better (Days taken less)
|
0 participants
|
3 participants
|
|
BARS: Medication Adherence
NA (Days taken less)
|
23 participants
|
22 participants
|
|
BARS: Medication Adherence
No Change (Days not taken)
|
17 participants
|
23 participants
|
|
BARS: Medication Adherence
Worse (Days not taken)
|
3 participants
|
3 participants
|
|
BARS: Medication Adherence
NA (Days not taken)
|
23 participants
|
22 participants
|
|
BARS: Medication Adherence
No Change (Days taken less)
|
16 participants
|
19 participants
|
|
BARS: Medication Adherence
Worse (Days taken less)
|
4 participants
|
4 participants
|
SECONDARY outcome
Timeframe: Baseline-6 months.Provider-Patient Clinical Alliance will be assessed with Scale to Assess the Therapeutic Relationship - Patient to measure patient perspective of provider-patient relationship. This 12-item measure employing a 5-point likert scale has been used extensively in studies of outpatient care for severe mental illness. This measure supports patient and provider versions. Higher values are better. Range 0-48.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
STAR-P: Patient Relationship With Clinician
Pre-Intervention
|
39.3 score on a scale
Standard Deviation 6.7
|
37.0 score on a scale
Standard Deviation 8.4
|
|
STAR-P: Patient Relationship With Clinician
Post-Intervention
|
38.0 score on a scale
Standard Deviation 8.2
|
36.1 score on a scale
Standard Deviation 7.1
|
|
STAR-P: Patient Relationship With Clinician
Pre-Post Change
|
-0.9 score on a scale
Standard Deviation 8.5
|
-1.9 score on a scale
Standard Deviation 7.3
|
SECONDARY outcome
Timeframe: Baseline-6 months.The Heinrichs-Carpenter Quality of Life Scale, has 21 items, is well validated for schizophrenia, and captures sense of purpose, motivation, emotional and social interaction, role functioning, and engagement in regular activities. Higher values are better. Range 0-126. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
QLS: Heinrichs-Carpenter Quality of Life Scale
Pre-Post Change
|
-4.6 score on a scale
Standard Deviation 30.1
|
4.2 score on a scale
Standard Deviation 19.2
|
|
QLS: Heinrichs-Carpenter Quality of Life Scale
Pre-Intervention
|
77.4 score on a scale
Standard Deviation 19.1
|
79.2 score on a scale
Standard Deviation 23.4
|
|
QLS: Heinrichs-Carpenter Quality of Life Scale
Post-Intervention
|
63.2 score on a scale
Standard Deviation 36.9
|
70.1 score on a scale
Standard Deviation 43.4
|
SECONDARY outcome
Timeframe: Baseline-6 months.Schizophrenia-specific symptomatology will be assessed with the Positive and Negative Syndrome Scale. Lower values are better. Range 30-210. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
PANSS: Schizophrenia Symptoms
Post-Intervention
|
48.0 score on a scale
Standard Deviation 11.6
|
45.1 score on a scale
Standard Deviation 17.5
|
|
PANSS: Schizophrenia Symptoms
Pre-Post Change
|
-6.1 score on a scale
Standard Deviation 14.3
|
-10.2 score on a scale
Standard Deviation 14.0
|
|
PANSS: Schizophrenia Symptoms
Pre-Intervention
|
54.0 score on a scale
Standard Deviation 14.4
|
56.1 score on a scale
Standard Deviation 16.0
|
SECONDARY outcome
Timeframe: Baseline-6 months.Global Appraisal of Individual Needs- Short Screener (GAIN-SS) - Instrument used for screening possible internalizing or externalizing psychiatric disorders, substance use disorders, or crime and violence problems. Lower values are better. Range 0-20. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
GAIN-SS
Pre-Intervention
|
5.1 score on a scale
Standard Deviation 5.3
|
5.8 score on a scale
Standard Deviation 5.8
|
|
GAIN-SS
Post-Intervention
|
3.3 score on a scale
Standard Deviation 4.5
|
5.1 score on a scale
Standard Deviation 5.7
|
|
GAIN-SS
Pre-Post Change
|
-1.2 score on a scale
Standard Deviation 3.7
|
0.2 score on a scale
Standard Deviation 5.5
|
SECONDARY outcome
Timeframe: Baseline-6 months.The 5-item, 6-point likert scale Medical Outcomes Study general adherence scale to capture broader adherence to treatment recommendations (again triangulated with provider responses). Higher values are better. Range 5-26. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
MOS: Treatment Adherence - General
Pre-Intervention
|
25.5 score on a scale
Standard Deviation 4.5
|
23.2 score on a scale
Standard Deviation 6.1
|
|
MOS: Treatment Adherence - General
Post-Intervention
|
23.2 score on a scale
Standard Deviation 5.8
|
23.0 score on a scale
Standard Deviation 5.9
|
|
MOS: Treatment Adherence - General
Pre-Post Change
|
-2.1 score on a scale
Standard Deviation 5.9
|
-0.5 score on a scale
Standard Deviation 4.9
|
SECONDARY outcome
Timeframe: Baseline-6 months.Population: No show vs. attending rates for both arms do not add up to 100% since an additional measure of cancelled rates was measured in the RCT. However, this variable was excluded from analysis since in the client's medical records it is unclear whether the clinician or client cancelled the appointment.
The average rate of scheduled appointments attended through EMR audit at CAMH or provider report at non-CAMH sites. No show vs. attending rates for both arms do not add up to 100% since an additional measure of cancelled rates was measured in the RCT. However, this variable was excluded from analysis since in the client's medical records it is unclear whether the clinician or client cancelled the appointment.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
Appointment Attendance
Attending Rate
|
82 percentage of scheduled visits
Standard Deviation 21
|
84 percentage of scheduled visits
Standard Deviation 18
|
|
Appointment Attendance
No-Show Rate
|
11 percentage of scheduled visits
Standard Deviation 19
|
9 percentage of scheduled visits
Standard Deviation 17
|
SECONDARY outcome
Timeframe: Baseline - 6 monthsPopulation: Only a subset of the participants had their clinician participate in the study with them.
Provider-Patient Clinical Alliance will be assessed with Scale to Assess the Therapeutic Relationship - Patient to measure patient perspective of provider-patient relationship. This 12-item measure employing a 5-point likert scale has been used extensively in studies of outpatient care for severe mental illness. This measure supports patient and provider versions. Higher values are better. Range 0-48. Pre-post change scores were calculated by subtracting the pre-score from the post score (= post - pre).
Outcome measures
| Measure |
Participants
n=18 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=17 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
STAR-C: Clinician Relationship With Patient
Pre-Intervention
|
36.2 score on a scale
Standard Deviation 3.7
|
36.9 score on a scale
Standard Deviation 2.9
|
|
STAR-C: Clinician Relationship With Patient
Post-Intervention
|
20.8 score on a scale
Standard Deviation 18.3
|
17.4 score on a scale
Standard Deviation 18.7
|
|
STAR-C: Clinician Relationship With Patient
Pre-Post Intervention
|
-3.2 score on a scale
Standard Deviation 10.5
|
-0.9 score on a scale
Standard Deviation 3.8
|
SECONDARY outcome
Timeframe: baseline - 6 monthsService Use History measure to assess past month service use history. Number of visits due to physical health issues (in the past 6 months) included the sum of: family doctor, ER, walk-in clinic, and other services Number of visits due to mental health issues (in the past 6 months) included the sum of: sum of family doctor, outpatient, psychologist, social worker, community service There is no limit on the scale range since it is based on the number of visits to various services in the past 6 months.
Outcome measures
| Measure |
Participants
n=43 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=48 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
SUH - Patients
Physical Health Appointment Baseline
|
5.3 service use visits
Standard Deviation 6.6
|
3.8 service use visits
Standard Deviation 4.4
|
|
SUH - Patients
Physical Health Appointment Follow-up
|
1.8 service use visits
Standard Deviation 1.5
|
4.2 service use visits
Standard Deviation 13.4
|
|
SUH - Patients
Mental Health Appointment Baseline
|
3.6 service use visits
Standard Deviation 4.6
|
3.9 service use visits
Standard Deviation 4.4
|
|
SUH - Patients
Mental Health Appointment Follow-up
|
13.2 service use visits
Standard Deviation 16.7
|
11.0 service use visits
Standard Deviation 10.2
|
SECONDARY outcome
Timeframe: Baseline - 6 monthsPopulation: Only a subset of the participants had a clinician participate with them.
Service Use History measure to assess past month service use history of patient participant. Number of visits due to physical health issues (in the past 6 months) included the sum of: family doctor, ER, walk-in clinic, and other services for the patient participant Number of visits due to mental health issues (in the past 6 months) included the sum of: sum of family doctor, outpatient, psychologist, social worker, community service for the patient participant There is no limit on the scale range since it is based on the number of visits to various services in the past 6 months.
Outcome measures
| Measure |
Participants
n=18 Participants
Participants that met eligibility criteria: Patient participants were adults, 18 years of age or older, with a schizophrenia spectrum disorder chart diagnosis verified by structured diagnostic interview (SCID-5). 22 They were engaged in outpatient mental health services, were proficient in English, and owned and used a smartphone (Android or iPhone).
|
Treatment As Usual
n=14 Participants
Treatment as usual participants will be recieving outpatient mental health care through the standard supports (most typically, case management and psychiatric support) that are available in a large, Canadian, urban centre.
|
|---|---|---|
|
SUH - Clinicians
Physical Health Appointments Baseline
|
1.1 service use visits
Standard Deviation 0.6
|
0.8 service use visits
Standard Deviation 0.4
|
|
SUH - Clinicians
Physical Health Appointments Follow-up
|
1.7 service use visits
Standard Deviation 1.2
|
1.7 service use visits
Standard Deviation 0.6
|
|
SUH - Clinicians
Mental Health Appointments Baseline
|
6.4 service use visits
Standard Deviation 5.4
|
8.1 service use visits
Standard Deviation 7.1
|
|
SUH - Clinicians
Mental Health Appointments Follow-up
|
5.4 service use visits
Standard Deviation 2.4
|
2.8 service use visits
Standard Deviation 2.3
|
Adverse Events
A4i Intervention
Treatment As Usual
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place